Microtest Diagnostics has named Kjell Kristiansen as group managing director.

Kristiansen joins Microtest from Phadia, where he was regional director for Asia for 14 years. Thermo Fisher acquired Phadia last year.

London-based Microtest said it made the appointment as it prepares to launch its microarray-based ADAM in vitro allergy and autoimmunity testing platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.